Retinal pigment epithelium wound healing in human Bruch's membrane explants

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 5, 2003, Pages 2199-2210

  Wang, Hao ^a   Ninomiya, Yoshihiko ^b   Sugino, Ilene K ^a   Zarbin, Marco A ^a,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE;

AGED; ARTICLE; BASEMENT MEMBRANE; BRUCH MEMBRANE; CELL MIGRATION; CELL VIABILITY; CHOROID; CLINICAL ARTICLE; DEBRIDEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MORPHOLOGY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SCANNING ELECTRON MICROSCOPY; SCLERA; WOUND HEALING;

AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; BRUCH MEMBRANE; CELL DIVISION; CELL MOVEMENT; CELL SURVIVAL; DEBRIDEMENT; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PIGMENT EPITHELIUM OF EYE; REGENERATION; WOUND HEALING;

EID: 0242416956     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0435     Document Type: Article

References (81)

1. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32:375-413.
2. Kahn HA, Moorehead HB. Statistics on blindness in the model reporting area 1967-1970. Washington, DC: US Dept. Health, Education and Welfare, 1973. Publication no. 73-426.
3. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
4. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24(suppl):335-610.
5. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325:1412-1417.
6. Ferris FL, Fine SL 3rd, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640-1642.
7. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol. 1983; 67:209-213.
8. Gibson JM, Lavery JR, Rosenthal AR. Blindness and partial sight in an elderly population. Br J Ophthalmol. 1986;70:700-705.
9. Jonasson F, Thordarson K. Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1984. Acta Ophthalmol Suppl. 1987;182:40-43.
10. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182-191.
11. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996;103:357-364.
12. Rosenberg T, Klie F. Current trends in newly registered blindness in Denmark. Acta Ophthalmol Scand. 1996;74:395-398.
13. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-210.
14. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450-1460.
15. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7-21.
16. Freund KB, Yannuzz LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol. 1993; 115:786-791.
17. Moisseiev J, Alhalel A, Masuri R, Treister G. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol. 1995; 113:185-189.
18. Group MPS [Macular Photocoagulation Study]. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1990;108:816-824.
19. Group MPS. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesion of ARMD. Arch Ophthalmol. 1990;108:825-831.
20. Group MPS. Argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol. 1991;109:1109-1114.
21. Group MPS. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol. 1993;111:1200-1209.
22. Group MPS. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol. 1994;112:480-488.
23. Group MPS. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol. 1994;112:489-499.
24. Group MPS. Subfoveal neovascular lesions in age related macular degeneration: guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol. 1991;109:1242- 1257.
25. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Arch Ophthalmol. 1999;117:1329-1345.
26. Bressler NM. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol. 2001;119:198- 207.
27. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001;131:541-560.
28. Olsen TW, Feng X, Kasper T, Rath PP, Steuer ER. Exudative age-related macular degeneration: fluorescein angiographic subtype prevalence [ARVO Abstract]. Invest Ophthalmol Vis Sci. 2001;42(4):S311. Abstract nr 1676.
29. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. Am J Ophthalmol. 2000;130:387-407.
30. Merrill PT, LoRusso FJ, Lomeo MD, et al. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology. 1999;106:782-789.
31. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology. 1994;101:1384-1396.
32. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes: short-term postoperative results. Ophthalmology. 1992;99:969-975; discussion 975-976.
33. Grossniklaus HE, Hutchinson AK, Capone AJ, et al. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology. 1994;101:1099-111.
34. Lopez PF, Grossniklaus HE, Lambert HM, et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112:647- 656.
35. Nasir MA, Sugino I, Zarbin MA. Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration. Br J Ophthalmol. 1997;81:481-489.
36. Castellarin AA, Nasir MA, Sugino IK, Zarbin MA. Clinicopathological correlation of primary and recurrent choroidal neovascularisation following surgical excision in age related macular degeneration. Br J Ophthalmol. 1998;82:480-487.
37. Hsu JK, Thomas MA, Ibanez H, et al. Clinicopathologic studies of an eye after submacular membranectomy for choroidal neovascularization. Retina. 1995;15:43-52.
38. Ormerod LD, Puklin JE, Frank RN. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration. Ophthalmology. 1994;101: 1201-1210.
39. Pollack JS, Del Priore LV, Smith ME, et al. Postoperative abnormalities of the choriocapillaris in exudative age-related macular degeneration. Br J Ophthalmol. 1996;80:314-318.
40. Rosa RH, Thomas MA, Green WR. Clinicopathologic correlation of submacular membranectomy with retention of good vision in a patient with age-related macular degeneration. Arch Ophthalmol. 1996;114:480-487.
41. Del Priore LV, Kaplan HJ, Hornbeck R, et al. Retinal pigment epithelia] debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol. 1996;122:629-643.
42. Hudson HL, Frambach DA, Lopez PF. Relation of the functional and structural fundus changes after submacular surgery for neovascular age-related macular degeneration. Br J Ophthalmol. 1995;79:417-423.
43. Korte GE, Burns MS, Bellhorn RW. Epithelium-capillary interactions in the eye: the retinal pigment epithelium and the choriocapillaris. Int Rev Cytol. 1989; 114:221-248.
44. Leonard DS, Zhang XG, Panozzo G, et al. Clinicopathologic correlation of localized retinal pigment epithelium debridement. Invest Ophthalmol Vis Sci. 1997;38:1094-1109.
45. Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci. 1994; 107:2459-2469.
46. Hergott GJ, Sandig M, Kalnins VI. Cytoskeletal organization of migrating retinal pigment epithelial cells during wound healing in organ culture. Cell Motil Cytoskeleton. 1989;13:83-93.
47. Hergott GJ, Kalnins VI. Expression of proliferating cell nuclear antigen in migrating retinal pigment epithelial cells during wound healing in organ culture. Exp Cell Res. 1991;195:307-314.
48. Hergott GJ, Nagai H, Kalnins VI. Inhibition of retinal pigment epithelial cell migration and proliferation with monoclonal antibodies against the beta I integrin subunit during wound healing in organ culture. Invest Ophthalmol Vis Sci. 1993;34:2761-2768.
49. Kalnins VI, Sandig M, Hergott GJ, et al. Microfilament organization and wound repair in retinal pigment epithelium. Biochem Cell Biol. 1995;73:709-722.
50. Kamei M, Lewis JM, Hayashi A, et al. A new wound healing model of retinal pigment epithelial cells in sheet culture. Curr Eye Res. 1996;15:714-718.
51. Verstaeten TC, Buzney SM, Macdonald SG, et al. Retinal pigment epithelium wound closure in vitro. Invest Ophthalmol Vis Sci. 1990;31:481-488.
52. MacDonald IM, Peters C, Chen MH. Effect of retinoic acid on wound healing of laser bums to porcine retinal pigment epithelium. Can J Ophthalmol. 1996;31:175-178.
53. Nicolaissen B. Argon laser lesions in the human RPE in vitro. Acta Ophthalmol. 1988;66:277-285.
54. Grierson I, Hiscott P, Hogg P, et al. Development, repair and regeneration of the retinal pigment epithelium. Eye. 1994;8:255-262.
55. Del Priore LV, Glaser BM, Quigley HA, et al. Morphology of pig retinal pigment epithelium maintained in organ culture. Arch Ophthalmol. 1988;106:1286-1290.
56. Del Priore LV, Glaser BM, Quigley HA, et al. Response of pig retinal pigment epithelium to laser photocoagulation in organ culture. Arch Ophthalmol. 1989;107:119-122.
57. Berger AS, Beaty CA, Bassnett S. Retinal pigment epithelial cell regeneration in organ culture [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S190. Abstract nr 908.
58. Kamei M, Kawasaki A, Tano Y. Analysis of extracellular matrix synthesis during wound healing of retinal pigment epithelial cells. Microsc Res Tech. 1998;42:311-316.
59. Goldbaum MH, Madden K. A new perspective on Bruch's membrane and the retinal pigment epithelium Br J Ophthalmol. 1982; 66:17-25.
60. Del Priore LV, Hornbeck R, Kaplan HJ, et al. Débridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol. 1995;113:939-944.
61. Valentino TL Kaplan HJ, Del Priore LV, et al. Retinal pigment epithelial repopulation in monkeys after submacular surgery. Arch Ophthalmol. 1995;113:932-938.
62. Goodman SL, Risse G, von der Mark K. The E8 subfragment of laminin promotes locomotion of myoblasts over extracellular matrix. J Cell Biol. 1989;109:799-809.
63. DiMilla PA, Stone JA, Quinn JA, Albelda SM, Lauffenburger DA. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol. 1993;122:729-737.
64. Bauer JS, Schreiner CL, Giancotti FG, Ruoslahti E, Juliano RL. Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins. J Cell Biol. 1992;116:477-487.
65. Giancotti FG, Ruoslahti E. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990;60:849-859.
66. Keely PJ, Fong AM, Zutter MM, Santoro SA. Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J Cell Sci. 1995;108:595-607.
67. Duband JL, Dufour S, Yamada SS, Yamada KM, Thiery JP. Neural crest cell locomotion induced by antibodies to beta 1 integrins: a tool for studying the roles of substratum molecular avidity and density in migration. J Cell Sci. 1991;98:517-532.
68. Kuijpers TW, Mul EP, Blom M, et al. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration. J Exp Med. 1993;178:279-284.
69. Huttenlocher A, Ginsberg MH, Horwitz AF. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand- binding affinity. J Cell Biol. 1996; 134:1551-1562.
70. Ho TC, Del Priore LV. Reattachment of cultured human retinal pigment epithelium to extracellular matrix and human Bruch's membrane. Invest Ophthalmol Vis Sci. 1997;38:1110-1118.
71. Das A, Frank RN, Zhang nl, Turczyn TJ. Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch's membrane. Arch Ophthalmol. 1990;108:421-429.
72. Mazure AGI. In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1992;33:3407-3416.
73. Hiscott PS, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol. 1984;68:708-715.
74. Machemer R, van Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978;85:181-191.
75. Mandelcorn MS, Machemer R, Fineberg E, Hersch SB. Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants. Am J Ophthalmol. 1975;80:227-237.
76. Vidaurri-Leal J, Hohman R, Glaser BM. Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells: a new approach to the study of proliferative vitreoretinopathy. Arch Ophthalmol 1984;102:1220-1223.
77. McKay BS, Burke JM. Separation of phenotypically distinct subpopulations of cultured human retinal pigment epithelial cells. Exp Cell Res. 1994;213:85-92.
78. Burke JM, Skumatz CM, Irving PE, McKay BS. Phenotypic heterogeneity of retinal pigment epithelial cells in vitro and in situ. Exp Eye Res. 1996;62:63-73.
79. Ozaki S, Kita M, Yamana T, Negi A, Honda Y. Influence of the sensory retina on healing of the rabbit retinal pigment epithelium. Curr Eye Res. 1997;16:349-358.
80. Marmorstein AD, Bonilha VL, Chiflet S, Neill JM, Rodriguez-Boulan E. The polarity of the plasma membrane protein RET-PE2 in retinal pigment epithelium is developmentally regulated. J Cell Sci. 1996;109:3025-3034.
81. Fisher SK, Stone J, Rex TS, Linberg KA, Lewis GP. Experimental retinal detachment: a paradigm for understanding the effects of induced photoreceptor degeneration. Prog Brain Res. 2001;131: 679-698.